Grape King Bio Ltd (TPE:1707)

Grape King Bio Revenue

Grape King Bio had revenue of 2.28B TWD in the quarter ending March 31, 2026, with 1.14% growth. This brings the company's revenue in the last twelve months to 10.28B, down -7.12% year-over-year. In the year 2025, Grape King Bio had annual revenue of 10.25B, down -8.14%.

• Revenue (ttm): 10.28B
• Revenue Growth: -7.12%
• P/S Ratio: 1.46
• Revenue / Employee: 20.51M
• Employees: 501
• Market Cap: 14.96B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	10.25B	-908.40M	-8.14%
Dec 31, 2024	11.16B	524.54M	4.93%
Dec 31, 2023	10.64B	244.23M	2.35%
Dec 31, 2022	10.39B	592.99M	6.05%
Dec 31, 2021	9.80B	630.05M	6.87%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 26, 2026

Data Sources Report a data error